Roche Drops NJ Boniva Suits After Teva Pulls ANDA

Law360, New York (November 3, 2009, 3:47 PM EST) -- Twin patent lawsuits brought by Hoffmann-La Roche Inc. accusing generic-drug maker Teva Pharmaceuticals USA Inc. and its Gate Pharmaceuticals division of infringing patents related to a popular osteoporosis drug have been dismissed because Teva dropped an application to make generic Boniva.

Judge Stanley R. Chesler's order, entered Monday in the U.S. District Court for the District of New Jersey, put the final stamp on the without-prejudice dismissals. Court papers noted the defendants had withdrawn an abbreviated new drug application relevant to the cases.

It was unclear...
To view the full article, register now.